Show
Sort by
-
Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study
-
MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy
-
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice
-
Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients
(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187 -
Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response and asthma control in preschool children with asthma
-
Olfaction in nasal polyp patients after Reboot surgery : an endotype-based prospective study
-
- Journal Article
- A1
- open access
Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors
-
- Journal Article
- A1
- open access
Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP
-
Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB195-AB195 -
Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma
-
Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial
-
Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB161-AB161 -
Symptom free days in patients with severe chronic rhinosinusitis with nasal polyps treated with dupilumab
-
Advances in chronic rhinosinusitis in 2020 and 2021
-
- Journal Article
- A1
- open access
Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies
-
- Journal Article
- A1
- open access
Chemokine expression-based endotype clustering of chronic rhinosinusitis
-
- Journal Article
- A1
- open access
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Mepolizumab for chronic rhinosinusitis with nasal polyps : treatment efficacy by comorbidity and blood eosinophil count
-
Reboot surgery for chronic rhinosinusitis with nasal polyposis : recurrence and smell kinetics
-
- Journal Article
- A1
- open access
Seasonal distribution of inhaled allergens in allergic asthma patients with or without allergic rhinitis
-
- Journal Article
- A1
- open access
IL-10 family cytokines in chronic rhinosinusitis with nasal polyps : from experiments to the clinic
-
- Journal Article
- A1
- open access
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
-
- Journal Article
- A1
- open access
Local immunoglobulin E in nasal polyps : role and modulation
-
Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Dupilumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem
-
- Journal Article
- A1
- open access
AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion
-
- Journal Article
- A1
- open access
Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes
-
- Journal Article
- A1
- open access
Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation
-
- Journal Article
- A1
- open access
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
-
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)
-
- Journal Article
- A1
- open access
Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
-
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials
-
- Journal Article
- A1
- open access
Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers
-
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial
-
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
The protease SplB of staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis
-
- Miscellaneous
- open access
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
-
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies
-
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds
-
The development of the mucosal concept in chronic rhinosinusitis and its clinical implications
-
A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Impact of dupilumab on sleep/function scores in patients with chronic rhinosinusitis with nasal polyps
(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 127(5). p.S53-S53 -
Association between dupilumab effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials
(2021) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 203(9S). p.A1343-A1343 -
- Journal Article
- A1
- open access
Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma